Abstract
Background Hypertension (HTN), a globally prevalent chronic condition, poses a significant public health challenge. Concurrently, abnormalities in bone metabolism, such as reduced bone mineral density (BMD) and osteoporosis (OP), profoundly affect the quality of life of affected individuals. This study aims to comprehensively investigate the relationship between HTN and bone metabolism abnormalities using data from the National Health and Nutrition Examination Survey (NHANES) and advanced machine learning techniques.
Methods Data were sourced from the NHANES database, covering the years 2009 to 2018. Specifically, femur and spine BMD measurements were obtained via dual-energy X-ray absorptiometry (DXA) for the 2009–2010 period, given the lack of full-body data. A predictive model was developed to estimate total body BMD from femur and spine measurements. The initial dataset comprised 49,693 individuals, and after rigorous data cleaning and exclusion of incomplete records, 7,566 participants were included in the final analysis. Data were processed and analyzed using SPSS, which facilitated descriptive statistical analysis, multivariate logistic regression, and multiple linear regression, alongside subgroup analyses to explore associations across different demographic groups. Machine learning algorithms, including neural networks, decision trees, random forests, and XGBoost, were utilized for cross-validation and hyperparameter optimization. The contribution of each feature to the model output was assessed using SHAP (Shapley Additive Explanations) values, enhancing the model’s accuracy and robustness.
Results Baseline characteristic analysis revealed that compared to the non-HTN group, the HTN group was significantly older (44.37 vs. 34.94 years, p < 0.001), had a higher proportion of males (76.8% vs. 60.7%, p < 0.001), higher BMI (31.21 vs. 27.77, p < 0.001), a higher smoking rate (54.4% vs. 41.2%, p < 0.001), and notably lower BMD (1.1507 vs. 1.1271, p < 0.001). When comparing the low bone mass group with the normal bone mass group, the former was older (36.02 vs. 34.5 years, p < 0.001), had a lower proportion of males (41.8% vs. 63.3%, p < 0.001), lower BMI (25.28 vs. 28.25, p < 0.001), and a higher incidence of HTN (10.9% vs. 8.6%, p = 0.006). Overall logistic and multiple linear regression analyses demonstrated a significant negative correlation between HTN and bone metabolism abnormalities (adjusted model Beta = −0.007, 95% CI: −0.013 to −0.002, p = 0.006). Subgroup analysis revealed a more pronounced association in males (Beta = −0.01, p = 0.004) and in the 40–59 age group (Beta = −0.01, p = 0.012). The machine learning models corroborated these findings, with SHAP value analysis consistently indicating a negative impact of HTN on BMD across various feature controls, thus demonstrating high explanatory power and robustness across different models.
Conclusion This study comprehensively confirms the significant association between HTN and bone metabolism abnormalities, utilizing NHANES data in conjunction with machine learning algorithms.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
National Natural Science Foundation of China (NSFC) (Grant Nos. 81974564, 82104730).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used (or will use) ONLY openly available human data that were originally located at: https://www.cdc.gov/nchs/nhanes/index.htm
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors All data produced in the present work are contained in the manuscript All data produced are available online at
